DK2138169T3 - Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere - Google Patents

Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere

Info

Publication number: DK2138169T3
Authority: DK; Denmark
Prior art keywords: hormones; release system; penetration promoters; transdermal release; transdermal
Prior art date: 2003-12-12

Application number

DK09173898.9T

Other languages

English (en)

Inventor

Thomas Langguth

Michael Dittgen

Petra Huber

Dirk Schenk

Stefan Bracht

Original Assignee

Bayer Ip Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-12

Filing date

2004-12-10

Publication date

2013-11-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2138169(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-10 Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh

2013-11-18 Application granted granted Critical

2013-11-18 Publication of DK2138169T3 publication Critical patent/DK2138169T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Botany (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK09173898.9T 2003-12-12 2004-12-10 Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere DK2138169T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03078881		2003-12-12
EP04078365A EP1541137B1 (en)	2003-12-12	2004-12-10	Transdermal delivery system of gestodene

Publications (1)

Publication Number	Publication Date
DK2138169T3 true DK2138169T3 (da)	2013-11-18

Family

ID=34924031

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK09173898.9T DK2138169T3 (da)	2003-12-12	2004-12-10	Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere
DK04078365.6T DK1541137T3 (da)	2003-12-12	2004-12-10	Transdermalt delivery system af gestoden

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK04078365.6T DK1541137T3 (da)	2003-12-12	2004-12-10	Transdermalt delivery system af gestoden

Country Status (23)

Country	Link
EP (2)	EP2138169B1 (da)
CN (1)	CN101843603B (da)
AR (1)	AR046762A1 (da)
AT (1)	ATE457168T1 (da)
CR (1)	CR8465A (da)
CY (2)	CY1110637T1 (da)
DE (1)	DE602004025444D1 (da)
DK (2)	DK2138169T3 (da)
ES (2)	ES2340925T3 (da)
GT (1)	GT200400262A (da)
HN (1)	HN2004000526A (da)
HR (2)	HRP20100254T1 (da)
JO (1)	JO2606B1 (da)
ME (1)	ME01069B (da)
MY (2)	MY144053A (da)
PE (1)	PE20051035A1 (da)
PL (2)	PL2138169T3 (da)
PT (2)	PT2138169E (da)
RS (2)	RS51260B (da)
SI (2)	SI1541137T1 (da)
SV (1)	SV2006001970A (da)
TW (1)	TWI257299B (da)
UA (1)	UA89766C2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1594483E (pt)	2003-02-21	2006-12-29	Schering Ag	Penso transdérmico estável aos uv
US8668925B2 (en)	2003-12-12	2014-03-11	Bayer Intellectual Property Gmbh	Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en)	2005-05-02	2015-02-24	Bayer Intellectual Property Gmbh	Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) *	2005-10-19	2007-04-26	Schering Ag	Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
WO2010042610A1 (en)	2008-10-08	2010-04-15	Agile Therapeutics, Inc.	Transdermal delivery
CA2740002C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
CA2740005C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
EP2410859A4 (en)	2009-03-27	2013-03-13	Agile Therapeutics Inc	TRANSDERMAL ADMINISTRATION
DE102010040299A1 (de) *	2010-09-06	2012-03-08	Bayer Schering Pharma Aktiengesellschaft	Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2015203180B2 (en) *	2010-09-06	2016-06-30	Bayer Intellectual Property Gmbh	Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
HRP20170292T1 (hr)	2010-09-06	2017-04-21	Bayer Intellectual Property Gmbh	Transdermalni flasteri niske doze s visokim otpuštanjem lijeka
HK1204287A1 (en) *	2012-01-27	2015-11-13	敏捷治疗公司	Transdermal hormone delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4081537A (en)	1975-10-10	1978-03-28	Schering Aktiengesellschaft	Δ15 -Steroids and pharmaceutical compositions thereof
JP3238389B2 (ja) *	1988-10-27	2001-12-10	シエーリングアクチエンゲゼルシヤフト	ゲストデン含有の経皮適用のための薬剤
PT99338A (pt)	1990-10-29	1992-10-30	Alza Corp	Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
US5512292A (en)	1990-10-29	1996-04-30	Alza Corporation	Transdermal contraceptive formulations methods and devices
DE4336557C2 (de)	1993-05-06	1997-07-17	Lohmann Therapie Syst Lts	Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) *	1993-08-26	1995-03-02	Schering Ag	Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de)	1994-02-18	1995-08-24	Schering Ag	Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en)	1996-04-24	1998-06-09	Rutgers, The State University Of New Jersey	Transdermal contraceptive delivery system and process
DE19906152B4 (de)	1999-02-10	2005-02-10	Jenapharm Gmbh & Co. Kg	Wirkstoffhaltige Laminate für Transdermalsysteme
EP1242012B1 (en)	1999-11-24	2009-12-30	Agile Therapeutics, Inc.	Improved transdermal contraceptive delivery system and process
DE10053375C1 (de) *	2000-10-27	2002-01-24	Lohmann Therapie Syst Lts	Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en)	2000-12-05	2007-10-01	Noven Pharma	Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

2004
- 2004-10-12 UA UAA200607580A patent/UA89766C2/ru unknown
- 2004-11-18 JO JO2004159A patent/JO2606B1/en active
- 2004-12-10 SV SV2004001970A patent/SV2006001970A/es not_active Application Discontinuation
- 2004-12-10 PL PL09173898T patent/PL2138169T3/pl unknown
- 2004-12-10 SI SI200431404T patent/SI1541137T1/sl unknown
- 2004-12-10 ES ES04078365T patent/ES2340925T3/es not_active Expired - Lifetime
- 2004-12-10 AT AT04078365T patent/ATE457168T1/de active
- 2004-12-10 AR ARP040104605A patent/AR046762A1/es not_active Application Discontinuation
- 2004-12-10 DK DK09173898.9T patent/DK2138169T3/da active
- 2004-12-10 EP EP09173898.9A patent/EP2138169B1/en not_active Expired - Lifetime
- 2004-12-10 RS RSP-2010/0202A patent/RS51260B/sr unknown
- 2004-12-10 MY MYPI20045107A patent/MY144053A/en unknown
- 2004-12-10 PT PT91738989T patent/PT2138169E/pt unknown
- 2004-12-10 TW TW093138443A patent/TWI257299B/zh not_active IP Right Cessation
- 2004-12-10 DE DE602004025444T patent/DE602004025444D1/de not_active Expired - Lifetime
- 2004-12-10 PT PT04078365T patent/PT1541137E/pt unknown
- 2004-12-10 GT GT200400262A patent/GT200400262A/es unknown
- 2004-12-10 PE PE2004001230A patent/PE20051035A1/es active IP Right Grant
- 2004-12-10 ES ES09173898.9T patent/ES2445690T3/es not_active Expired - Lifetime
- 2004-12-10 SI SI200432127T patent/SI2138169T1/sl unknown
- 2004-12-10 PL PL04078365T patent/PL1541137T3/pl unknown
- 2004-12-10 ME MEP-2010-79A patent/ME01069B/me unknown
- 2004-12-10 CN CN2010101564978A patent/CN101843603B/zh not_active Expired - Lifetime
- 2004-12-10 DK DK04078365.6T patent/DK1541137T3/da active
- 2004-12-10 HN HN2004000526A patent/HN2004000526A/es unknown
- 2004-12-10 EP EP04078365A patent/EP1541137B1/en not_active Expired - Lifetime
- 2004-12-10 RS YU20140050A patent/RS53182B/sr unknown
2006
- 2006-06-20 CR CR8465A patent/CR8465A/es unknown
2010
- 2010-03-31 MY MYPI2010001448 patent/MY152750A/en unknown
- 2010-05-04 HR HR20100254T patent/HRP20100254T1/hr unknown
- 2010-05-07 CY CY20101100401T patent/CY1110637T1/el unknown
2014
- 2014-01-24 HR HRP20140077TT patent/HRP20140077T1/hr unknown
- 2014-02-06 CY CY20141100099T patent/CY1115064T1/el unknown

Also Published As

Publication number	Publication date
CN101843603B (zh)	2012-06-27
PT1541137E (pt)	2010-05-17
ATE457168T1 (de)	2010-02-15
CN101843603A (zh)	2010-09-29
EP2138169A3 (en)	2011-04-06
EP1541137B1 (en)	2010-02-10
CR8465A (es)	2007-06-06
HK1074801A1 (en)	2005-11-25
PL1541137T3 (pl)	2010-07-30
JO2606B1 (en)	2011-11-01
ES2340925T3 (es)	2010-06-11
CY1110637T1 (el)	2015-04-29
EP1541137A3 (en)	2005-11-16
CY1115064T1 (el)	2016-12-14
PE20051035A1 (es)	2006-02-08
MY152750A (en)	2014-11-28
DK1541137T3 (da)	2010-04-26
MY144053A (en)	2011-08-15
ME01069B (me)	2012-10-20
HRP20140077T1 (hr)	2014-02-28
EP1541137A2 (en)	2005-06-15
EP2138169B1 (en)	2013-11-06
PL2138169T3 (pl)	2014-04-30
DE602004025444D1 (de)	2010-03-25
AR046762A1 (es)	2005-12-21
SV2006001970A (es)	2006-02-16
HK1132682A1 (en)	2010-03-05
HRP20100254T1 (hr)	2010-06-30
HN2004000526A (es)	2010-02-01
ES2445690T3 (es)	2014-03-04
RS51260B (sr)	2010-12-31
TWI257299B (en)	2006-07-01
RS53182B (sr)	2014-06-30
GT200400262A (es)	2005-10-31
TW200528073A (en)	2005-09-01
SI1541137T1 (sl)	2010-06-30
EP2138169A2 (en)	2009-12-30
UA89766C2 (en)	2010-03-10
SI2138169T1 (sl)	2014-03-31
PT2138169E (pt)	2014-02-17

Publication	Publication Date	Title
HUS1900026I1 (hu)	2022-04-28	FVIII helyspecifikus módosítása
DE602005012267D1 (de)	2009-02-26	N von geräten
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DE602005018974D1 (de)	2010-03-04	Schnappschuss-System und Verfahren
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
DK2363114T3 (da)	2015-06-22	Opretholdt afgivelse af anti-infektionsmidler
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
DK1830850T3 (da)	2011-06-14	Quinolin-derivater til behandling af latent tuberkulose
DK1677214T3 (da)	2014-05-19	Udvideligt filsystem
DK2138169T3 (da)	2013-11-18	Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere
ATE380017T1 (de)	2007-12-15	Kontrolliertes freisetzungssystem enthaltend saccharoseacetatisobutyrat
DE602005000717D1 (de)	2007-05-03	Druckempfindliches Klebeband
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
DE602005027308D1 (de)	2011-05-19	Stabile salze von olanzapin
ATE398450T1 (de)	2008-07-15	Derivate von aryl-chinazolin/aryl-2amino-phenyl- methanon zurförderung der freisetzung von parathormon
DK1737971T3 (da)	2017-11-13	Blandinger af bindingsproteiner
DK1516540T3 (da)	2012-11-26	Anvendelse af vitamin D-forbindelser
ATE453699T1 (de)	2010-01-15	Klebstoffe
DE60234341D1 (de)	2009-12-24	Chinazoline derivative zur förderung der freisetzung von parathyroidmshormonen
DK1763520T3 (da)	2009-02-09	Anvendelse af trisubstituerede benzopyranoner
SE0400685D0 (sv)	2004-03-19	Means for transdermal administration of nicotine
IL176112A0 (en)	2006-10-05	Transdermal delivery system of hormones without penetration enhancers
DK1812002T3 (da)	2012-02-06	Behandling af mastitis
DE602005021943D1 (de)	2010-08-05	Haftverband
DK1794111T3 (da)	2014-10-13	Fremgangsmåde til fremstilling af cyclopentanon